Sirona Biochem Corp V.SBM

New JUVÉDERM Product

[Turtle4]

Interesting study of the new JUVDERM Product Product:

https://news.abbvie.com/news/press-releases/skinvive-by-juvderm-receives-us-fda-approval.htm

TFC-326 should be clearly superior here, and without needles. 
Especially the warnings and side effects are interesting.
And they make 1.4 billion a year with JUVDERM

[biorun]

Important reference point for 1326 as a reflection of new tech in same market space. Makes one wonder what AbbVie could do with 1067 as well. It's definitely a good thing they get % royalty on that one. But for the moment even a percentage of zero is still zero. This juvederm still requires injection, and isolated application to cheek area.  Bio is swirling with deeper pocket investors